Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Xingjian Lin"'
Autor:
Wenwen Xu, Guanjie Hu, Chen Xue, Honglin Ge, Jiu Chen, Wenzhang Qi, Xingjian Lin, Shanshan Chen, Yu Song, Ju Gao
Publikováno v:
Journal of Alzheimer's Disease. 83:111-126
Background: Anosognosia, or unawareness of memory deficits, is a common manifestation of Alzheimer’s disease (AD), but greatly variable in subjective cognitive decline (SCD) and amnestic mild cognitive impairment (aMCI) subjects. Self-referential n
Autor:
Wenying Ma, Wenwen Xu, Wenzhang Qi, Guanjie Hu, Shanshan Chen, Lin Dong, Xingjian Lin, Jiu Chen, Chen Xue
Publikováno v:
Journal of Alzheimer's Disease. 77:1495-1512
Background: Voxel-based morphometry studies have not yielded consistent results among patients with mild cognitive impairment (MCI) and subjective cognitive decline (SCD). Objective: Therefore, we aimed to conduct a meta-analysis of gray matter (GM)
Publikováno v:
Current Neuropharmacology
Although over 25 antiepileptic drugs (AEDs) have become currently available for clinical use, the incidence of epilepsy worldwide and the proportions of drug-resistant epilepsy among them are not significantly reduced during the past decades. Traditi
Publikováno v:
Seizure. 72:40-45
Purpose This study aimed to assess the cause and cause-specific risks of hospitalization for epilepsy patients in East China. Further analysis was performed for inpatient hospitalization days, hospital mortality and costs. Method This study was perfo
Publikováno v:
Brain Research. 1718:46-52
Objective The activation of renin angiotensin system is involved in multiple pathological processes. Growing evidence reveal that Angiotensin II (Ang II) contributes to the pathogenesis of Alzheimer disease (AD). However, the underlying mechanisms ar
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Frontiers in Neurology
Frontiers in Neurology
Anti–α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis is a rare autoimmune disease that is characterized by acute cognitive impairment, mental symptoms, and seizures. The high comorbidity rate between anti–AMPA r
Autor:
Yu Song, Wenwen Xu, Shanshan Chen, Guanjie Hu, Honglin Ge, Chen Xue, Wenzhang Qi, Xingjian Lin, Jiu Chen
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
Frontiers in Aging Neuroscience
Frontiers in Aging Neuroscience
Background Mild cognitive impairment (MCI) is an intermediate stage between normal aging and dementia. Amnestic MCI (aMCI) and non-amnestic MCI are the two subtypes of MCI with the former having a higher risk for progressing to Alzheimer's disease (A
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
Frontiers in Aging Neuroscience
Frontiers in Aging Neuroscience
Background: The spectrum of early Alzheimer's disease (AD) is thought to include subjective cognitive impairment, early mild cognitive impairment (eMCI), and late mild cognitive impairment (lMCI). Choline dysfunction affects the early progression of
Autor:
Xingjian Lin, Ailiang Miao, Ji-hong Zhang, Junxiong Yin, Donglin Zhu, Dao-wen Chen, Jie Lu, Jingping Shi
Publikováno v:
BMC Neurology, Vol 19, Iss 1, Pp 1-6 (2019)
BMC Neurology
BMC Neurology
Background Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis, which is the most common type of autoimmune encephalitis, is caused by the production of autoantibodies against NMDA receptor. Anti-NMDAR encephalitis patients present with vari
Autor:
Wenwen Xu, Shanshan Chen, Chen Xue, Guanjie Hu, Wenying Ma, Wenzhang Qi, Xingjian Lin, Jiu Chen
Publikováno v:
Frontiers in Aging Neuroscience, Vol 12 (2020)
Frontiers in Aging Neuroscience
Frontiers in Aging Neuroscience
Background: Mild cognitive impairment (MCI) is regarded as a transitional stage between normal aging and Alzheimer's disease (AD) dementia. MCI individuals with deficits in executive function are at higher risk for progressing to AD dementia. Current